{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:27:45Z","timestamp":1780482465952,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,10,14]],"date-time":"2010-10-14T00:00:00Z","timestamp":1287014400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1546-0096-8-26","type":"journal-article","created":{"date-parts":[[2010,10,15]],"date-time":"2010-10-15T14:16:04Z","timestamp":1287152164000},"source":"Crossref","is-referenced-by-count":16,"title":["HLA B27 allele types in homogeneous groups of juvenile idiopathic arthritis patients in Latvia"],"prefix":"10.1186","volume":"8","author":[{"given":"Valda","family":"Stanevicha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Eglite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dace","family":"Zavadska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturs","family":"Sochnevs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arina","family":"Lazareva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinara","family":"Guseinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruta","family":"Shantere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dace","family":"Gardovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,14]]},"reference":[{"key":"400_CR1","first-page":"367","volume":"17","author":"BA G\u00e4re","year":"1999","unstructured":"G\u00e4re BA: Juvenile arthritis: who gets it, where and when? A review of current data on incidence and prevalence. Clin Exp Rheumatol. 1999, 17: 367-374.","journal-title":"Clin Exp Rheumatol"},{"key":"400_CR2","volume-title":"Elsevier","author":"JT Cassidy","year":"2005","unstructured":"Cassidy JT, Petty RE, Laxer RM: Textbook of pediatric rheumatology. Elsevier. 2005, Philadelphia, 5","edition":"5"},{"key":"400_CR3","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1093\/rheumatology\/41.12.1428","volume":"41","author":"JC Packham","year":"2002","unstructured":"Packham JC, Hall MA: Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatology. 2002, 41: 1428-1435. 10.1093\/rheumatology\/41.12.1428.","journal-title":"Rheumatology"},{"key":"400_CR4","first-page":"1991","volume":"25","author":"RE Petty","year":"1998","unstructured":"Petty RE, Southwood TR, Baum J: Revision of the proposed criteria for idiopathic arthritis: Durban 1997. Journal of Rheumatology. 1998, 25: 1991-1994.","journal-title":"Journal of Rheumatology"},{"key":"400_CR5","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/S0140-6736(73)91360-3","volume":"1","author":"DA Brewerton","year":"1973","unstructured":"Brewerton DA, Hart FD, Nicholls A, Caffrey M: Ankylosing spondylitis and HL-A 27. Lancet. 1973, 1: 904-907. 10.1016\/S0140-6736(73)91360-3.","journal-title":"Lancet"},{"key":"400_CR6","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1056\/NEJM197304052881403","volume":"288","author":"L Schlosstein","year":"1973","unstructured":"Schlosstein L, Terasaki PI, Bluestone R, Pearson CM: High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med. 1973, 288: 704-706. 10.1056\/NEJM197304052881403.","journal-title":"N Engl J Med"},{"key":"400_CR7","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/S1297-319X(01)00294-9","volume":"68","author":"EJ Ball","year":"2001","unstructured":"Ball EJ, Khan MA: HLA-B27 polymorphism. Joint Bone Spine. 2001, 68: 378-382. 10.1016\/S1297-319X(01)00294-9.","journal-title":"Joint Bone Spine"},{"key":"400_CR8","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/ar591","volume":"4","author":"W Thomson","year":"2002","unstructured":"Thomson W, Donn R: Juvenile idiopathic arthritis genetics - what's new? What's next?. Arthritis Res. 2002, 4: 302-306. 10.1186\/ar591.","journal-title":"Arthritis Res"},{"issue":"5","key":"400_CR9","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/01.bor.0000240363.09218.61","volume":"18","author":"L Gensler","year":"2006","unstructured":"Gensler L, Davis JC: Recognition and treatment of juvenile-onset spondyloarthritis. Curr Opin Rheumatol. 2006, 18 (5): 507-511. 10.1097\/01.bor.0000240363.09218.61.","journal-title":"Curr Opin Rheumatol"},{"key":"400_CR10","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A: Juvenile idiopathic arthritis. Lancet. 2007, 369: 767-778. 10.1016\/S0140-6736(07)60363-8.","journal-title":"Lancet"},{"key":"400_CR11","first-page":"569","volume":"23","author":"R Burgos-Vargas","year":"1997","unstructured":"Burgos-Vargas R, Pacheco-Tena C, Vazquez-Mellado J: Juvenile-onset spondyloarthropathies. Pediatr Rheumatol. 1997, 23: 569-598.","journal-title":"Pediatr Rheumatol"},{"key":"400_CR12","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1056\/NEJM197404182901608","volume":"290","author":"GS Rachelefsky","year":"1974","unstructured":"Rachelefsky GS, Teresaki PI, Katz R: Increased prevalence of Bw27 in juvenile rheumatoid arthritis. N Engl J Med. 1974, 290: 892-893. 10.1056\/NEJM197404182901608.","journal-title":"N Engl J Med"},{"issue":"8","key":"400_CR13","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1002\/art.22807","volume":"56","author":"D Taurog Joel","year":"2007","unstructured":"Taurog Joel D: The Mystery of HLA-B27: If It Isn't One Thing, It's Another. Arthritis & Rheumatism. 2007, 56 (8): 2478-2481.","journal-title":"Arthritis & Rheumatism"},{"issue":"suppl 3","key":"400_CR14","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1186\/ar571","volume":"4","author":"A McMichael","year":"2002","unstructured":"McMichael A, Bowness P: HLA-B27: natural function and pathogenic role in spondyloarthritis. Arthritis Res. 2002, 4 (suppl 3): S153-S158. 10.1186\/ar571.","journal-title":"Arthritis Res"},{"issue":"49","key":"400_CR15","doi-asserted-by":"publisher","first-page":"47844","DOI":"10.1074\/jbc.M206392200","volume":"277","author":"M H\u00fclsmeyer","year":"2002","unstructured":"H\u00fclsmeyer M, Hillig RC, Volz A, R\u00fchl M: HLA-B27 Subtypes Differentially Associated with Disease Exhibit Subtle Structural Alterations. J Biol Chem. 2002, 277 (49): 47844-47853. 10.1074\/jbc.M206392200.","journal-title":"J Biol Chem"},{"key":"400_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1479-8077.2005.00152.x","volume":"8","author":"N Akkoc","year":"2005","unstructured":"Akkoc N, Khan MA: Etiopathogenic role of HLA-B27 alleles in ankylosing spondylitis. APLAR Journal of Rheumatology. 2005, 8: 146-153. 10.1111\/j.1479-8077.2005.00152.x.","journal-title":"APLAR Journal of Rheumatology"},{"key":"400_CR17","first-page":"845","volume":"28","author":"CD Brooks","year":"2001","unstructured":"Brooks CD: Sulfasalazine for the management of juvenile rheumatoid arthritis. J Rheumatol. 2001, 28: 845-853.","journal-title":"J Rheumatol"},{"key":"400_CR18","first-page":"124","volume":"13","author":"H Ozdogan","year":"1986","unstructured":"Ozdogan H, Turunc M, Deringol B: Sulphasalazine in the treatment of juvenile rheumatoid arthritis: a preliminary open trial. J Rheumatol. 1986, 13: 124-125.","journal-title":"J Rheumatol"},{"key":"400_CR19","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1136\/ard.2006.064717","volume":"66","author":"Van Rossum","year":"2007","unstructured":"Van Rossum : Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment. Ann Rheum Dis. 2007, 66: 1518-1524. 10.1136\/ard.2006.064717.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"400_CR20","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/BOR.0b013e32825a6a68","volume":"19","author":"S Ringold","year":"2007","unstructured":"Ringold S, Wallace CA, Hart JA: Measuring Clinical Response and Remission in Juvenile Idiopathic Arthritis: Measures of Disease Activity. Curr Opin Rheumatol CME. 2007, 19 (5): 471-476. 10.1097\/BOR.0b013e32825a6a68.","journal-title":"Curr Opin Rheumatol CME"},{"issue":"7","key":"400_CR21","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","volume":"40","author":"EH Giannini","year":"1997","unstructured":"Giannini EH, Ruperto N, Ravelli A, Lovell DJ: Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997, 40 (7): 1202-1209.","journal-title":"Arthritis Rheum"},{"key":"400_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/00000441-199810000-00004","volume":"316","author":"JD Reveille","year":"1998","unstructured":"Reveille JD: HLA-B27 and the seronegative spondyloarthropathies. Am J Med Sci. 1998, 316: 239-249. 10.1097\/00000441-199810000-00004.","journal-title":"Am J Med Sci"},{"key":"400_CR23","first-page":"560","volume":"13","author":"M Frosch","year":"1995","unstructured":"Frosch M, Ganser G, Herter B: Treatment of juvenile rheumatoid pauciarthritis with sulphasalazine. Clin Exp Rheumatol. 1995, 13: 560-566.","journal-title":"Clin Exp Rheumatol"},{"key":"400_CR24","first-page":"360","volume":"23","author":"LF Imundo","year":"1996","unstructured":"Imundo LF, Jacobs JC: Sulfasalazine therapy for juvenile rheumatoid arthritis. J Rheumatol. 1996, 23: 360-366.","journal-title":"J Rheumatol"},{"key":"400_CR25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/BF01450892","volume":"17","author":"JL Huang","year":"1998","unstructured":"Huang JL, Chen LC: Sulphasalazine in the treatment of children with chronic arthritis. Clin Rheumatol. 1998, 17: 359-363. 10.1007\/BF01450892.","journal-title":"Clin Rheumatol"},{"key":"400_CR26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/BF02231781","volume":"12","author":"A Gedalia","year":"1993","unstructured":"Gedalia A, Barash J, Press J, Buskila D: Sulphasalazine in the treatment of pauciarticular-onset juvenile chronic arthritis. Clin Rheumatol. 1993, 12: 511-514. 10.1007\/BF02231781.","journal-title":"Clin Rheumatol"},{"key":"400_CR27","first-page":"221","volume":"32","author":"AM Romicka","year":"1994","unstructured":"Romicka AM, Siemienska-Rywik S, Rostropowicz-Denisiewicz K: An assessment of the results of sulfasalazine treatment in patients with juvenile rheumatoid arthritis. Reumatologia. 1994, 32: 221-225.","journal-title":"Reumatologia"},{"key":"400_CR28","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/1529-0131(199805)41:5<808::AID-ART6>3.0.CO;2-T","volume":"41","author":"MAJ Van Rossum","year":"1998","unstructured":"Van Rossum MAJ, Fiselier TJW, Fransen MJAM: Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo controlled, multi-center study. Dutch Juvenile Chronic Arthritis Study Group. Arthritis Rheum. 1998, 41: 808-816. 10.1002\/1529-0131(199805)41:5<808::AID-ART6>3.0.CO;2-T.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"400_CR29","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1136\/ard.61.10.941","volume":"61","author":"R Burgos-Vargas","year":"2002","unstructured":"Burgos-Vargas R, Vazquez-Mellado J, Pacheco-Tena C, Hernandez-Garduno A: A 26 week randomised double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies. Ann Rheum Dis. 2002, 61 (10): 941-942. 10.1136\/ard.61.10.941.","journal-title":"Ann Rheum Dis"},{"key":"400_CR30","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/ar591","volume":"4","author":"W Thomson","year":"2002","unstructured":"Thomson W, Donn R: Juvenile idiopathic arthritis genetics - What's new? What's next?. Arthritis Res. 2002, 4: 302-306. 10.1186\/ar591.","journal-title":"Arthritis Res"},{"issue":"10","key":"400_CR31","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1128\/CVI.00169-07","volume":"14","author":"G Ahlenstiel","year":"2007","unstructured":"Ahlenstiel G, Roomp K, Daumer M, Nattermann J, Vogel M: Selective Pressures of HLA Genotypes and Antiviral Therapy on Human Immunodeficiency Virus Type 1 Sequence Mutation at a Population Level. Clin.Vaccine Immunol. 2007, 14 (10): 1266-1273. 10.1128\/CVI.00169-07.","journal-title":"Clin.Vaccine Immunol"},{"key":"400_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1742-6405-6-22","volume":"6","author":"S Likanonsakul","year":"2009","unstructured":"Likanonsakul S, Rattanatham T, Feangvad S, Uttayamakul S: HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients. AIDS Research and Therapy. 2009, 6: 22-10.1186\/1742-6405-6-22.","journal-title":"AIDS Research and Therapy"},{"issue":"4","key":"400_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0198-8859(98)00010-X","volume":"59","author":"A Aimarri","year":"1996","unstructured":"Aimarri A, Al Dwick N, Al Kabi S, Sleem K: Interferon- \u03b1 Therapy in HCV Hepatitis: HLA Phenotype and Cirrhosis are Independent Predictors of Clinical Outcome. Human Immunol. 1996, 59 (4): 239-242. 10.1016\/S0198-8859(98)00010-X.","journal-title":"Human Immunol"},{"key":"400_CR34","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1212\/WNL.57.11.1976","volume":"57","author":"C Fusco","year":"2001","unstructured":"Fusco C, Andreone V, Coppola G, Luongo V: HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis. Neurology. 2001, 57: 1976-1979.","journal-title":"Neurology"},{"key":"400_CR35","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1212\/WNL.0b013e3181c980fb","volume":"74","author":"D Pappas","year":"2010","unstructured":"Pappas D, Oksenberg J: Maximizing efficacy of therapy. Neurology. 2010, 74: S62-S69. 10.1212\/WNL.0b013e3181c980fb.","journal-title":"Neurology"},{"issue":"10","key":"400_CR36","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1093\/rheumatology\/kel208","volume":"45","author":"I Olivieri","year":"2006","unstructured":"Olivieri I, Scarano E, Gigliotti P, Padula A: Successful treatment of juvenile - onset HLA-B27- associated severe and refractory heel Thesitis with adalimumab documented by magnetic resonance imaging. Rheumatology. 2006, 45 (10): 1315-1317. 10.1093\/rheumatology\/kel208.","journal-title":"Rheumatology"},{"issue":"10","key":"400_CR37","first-page":"1903","volume":"31","author":"P Shah","year":"2004","unstructured":"Shah P, Griffith S, Shandforth M, Fisher J, Dawes P: Can gold therapy be used safely in rheumatoid arthritis? Adverse drug reactions are more likely in patients with nodular disease, independent of HLA-DR3 status. J Rheumatol. 2004, 31 (10): 1903-5.","journal-title":"J Rheumatol"},{"key":"400_CR38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1399-0039.1992.tb01940.x","volume":"39","author":"O Olerup","year":"1992","unstructured":"Olerup O, Zetterquist H: HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens. 1992, 39: 225-235. 10.1111\/j.1399-0039.1992.tb01940.x.","journal-title":"Tissue Antigens"},{"key":"400_CR39","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 1988, 16: 1215-1218. 10.1093\/nar\/16.3.1215.","journal-title":"Nucleic Acid Res"},{"key":"400_CR40","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1399-0039.1995.tb03127.x","volume":"46","author":"M Bunce","year":"1995","unstructured":"Bunce M, O'Neill CM, Barnardo MCN, Krausa P, Browning MJ, Morris PJ: Photoytping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilising sequence-specific primers (PCR-SSP). Tissue Antigens. 1995, 46: 355-367. 10.1111\/j.1399-0039.1995.tb03127.x.","journal-title":"Tissue Antigens"},{"key":"400_CR41","first-page":"969","volume-title":"Pascal program by ELF Franco & N Compos-Filho Ludwig Cancer Institute: Mathematics Software StatCalc","author":"CR Mehta","year":"1985","unstructured":"Mehta CR, Patel NR, Gay RJ: Pascal program by ELF Franco & N Compos-Filho Ludwig Cancer Institute: Mathematics Software StatCalc. 1985, S\u00e3o Paulo, Brazil: Am. Stat. Assoc, 78: 969-973."},{"key":"400_CR42","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/1529-0131(199909)42:9<1843::AID-ANR8>3.0.CO;2-M","volume":"42","author":"KJ Murray","year":"1999","unstructured":"Murray KJ, Moroldo MB, Donnelly P: Age specific effects of juvenile rheumatoid arthritis-associated alleles. Arthritis Rheum. 1999, 42: 1843-1853. 10.1002\/1529-0131(199909)42:9<1843::AID-ANR8>3.0.CO;2-M.","journal-title":"Arthritis Rheum"},{"key":"400_CR43","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/S0198-8859(01)00299-3","volume":"62","author":"MA Blanco-Gelaz","year":"2001","unstructured":"Blanco-Gelaz MA, Lopez-Vazquez A, Garcia-Fernandez S, Martinez-Borra J, Gonzalez S, Lopez-Larrea C: Genetic variability, molecular evolution, and geographic diversity of HLA-B27. Hum Immunol. 2001, 62: 1042-1050. 10.1016\/S0198-8859(01)00299-3.","journal-title":"Hum Immunol"},{"key":"400_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1399-0039.1997.tb02713.x","volume":"49","author":"EC Ren","year":"1997","unstructured":"Ren EC, Koh WH, Sim D, Boey ML, Wee GB, Chan SH: Possible protective role of HLA-B*2706 for ankylosing spondylitis. Tissue Antigens. 1997, 49: 67-69. 10.1111\/j.1399-0039.1997.tb02713.x.","journal-title":"Tissue Antigens"},{"key":"400_CR45","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/rheumatology\/41.10.1183","volume":"41","author":"W Thomson","year":"2002","unstructured":"Thomson W, Barrett JH, Donn R: Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients. Rheumatology. 2002, 41: 1183-1189. 10.1093\/rheumatology\/41.10.1183.","journal-title":"Rheumatology"},{"key":"400_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/03009740601089259","volume":"36","author":"C Pruunsild","year":"2007","unstructured":"Pruunsild C, Uibo K, Liivam\u00e4gi H, Tarraste S: Incidence of juvenile idiopathic arthritis in children in Estonia: a prospective population-based study. Scand J Rheumatol. 2007, 36: 7-13. 10.1080\/03009740601089259.","journal-title":"Scand J Rheumatol"},{"issue":"10","key":"400_CR47","first-page":"2055","volume":"35","author":"L Berntson","year":"2008","unstructured":"Berntson L, Damgard M: For the Nordic Paediatric Rheumatology Study HLA-B27 Predicts a More Extended Disease with Increasing Age at Onset in Boys with Juvenile Idiopathic Arthritis. J Rheumatol. 2008, 35 (10): 2055-2061.","journal-title":"J Rheumatol"},{"issue":"4","key":"400_CR48","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.survophthal.2005.04.003","volume":"50","author":"JH Chang","year":"2005","unstructured":"Chang JH, Mc Cluskey PJ, Wakefield D: Acute anterior uveitis and HLA-B27. Surv Ophthalmol. 2005, 50 (4): 364-388. 10.1016\/j.survophthal.2005.04.003.","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"400_CR49","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/bjo.84.4.413","volume":"84","author":"M Huhtinen","year":"2000","unstructured":"Huhtinen M, Karma A: HLA-B27 typing in the categorisation of uveitis in a HLA-B27 rich population. Br J Ophthalmol. 2000, 84 (4): 413-6. 10.1136\/bjo.84.4.413.","journal-title":"Br J Ophthalmol"},{"key":"400_CR50","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1001\/jama.294.13.1671","volume":"294","author":"PJ Hashkes","year":"2005","unstructured":"Hashkes PJ, Laxer RM: Medical Treatment of Juvenile Idiopathic Arthritis. JAMA. 2005, 294: 1671-1684. 10.1001\/jama.294.13.1671.","journal-title":"JAMA"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1546-0096-8-26.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1546-0096-8-26\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1546-0096-8-26.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T14:24:38Z","timestamp":1548080678000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/1546-0096-8-26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,14]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["400"],"URL":"https:\/\/doi.org\/10.1186\/1546-0096-8-26","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,14]]},"article-number":"26"}}